S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48
S&P 500   4,532.76
DOW   35,028.65
QQQ   366.48

AXIM Biotechnologies Stock Forecast, Price & News

+0.01 (+4.50%)
(As of 01/19/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
282,650 shs
Average Volume
225,752 shs
Market Capitalization
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive AXIM News and Ratings via Email

Sign-up to receive the latest news and ratings for AXIM Biotechnologies and its competitors with MarketBeat's FREE daily newsletter.

AXIM Biotechnologies logo

About AXIM Biotechnologies

AXIM Biotechnologies, Inc. operates as a biotechnology company. It focuses in the research, development and production of pharmaceutical, nutraceutical, cosmetic and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.


Upper Axim Nkosuohemaa Destooled
September 17, 2021 |  msn.com
See More Headlines

Industry, Sector and Symbol

Current Symbol
Year Founded

Sales & Book Value

Annual Sales


Pretax Margin




Free Float
Not Optionable


Overall MarketRank

0.80 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

AXIM Biotechnologies (OTCMKTS:AXIM) Frequently Asked Questions

How has AXIM Biotechnologies' stock price been impacted by Coronavirus (COVID-19)?

AXIM Biotechnologies' stock was trading at $0.1781 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, AXIM shares have increased by 30.3% and is now trading at $0.2321.
View which stocks have been most impacted by COVID-19

Are investors shorting AXIM Biotechnologies?

AXIM Biotechnologies saw a increase in short interest in the month of December. As of December 15th, there was short interest totaling 27,300 shares, an increase of 47.6% from the November 30th total of 18,500 shares. Based on an average daily trading volume, of 285,300 shares, the short-interest ratio is currently 0.1 days.
View AXIM Biotechnologies' Short Interest

Who are AXIM Biotechnologies' key executives?

AXIM Biotechnologies' management team includes the following people:
  • John W. Huemoeller, President, Chief Executive Officer & Director
  • Robert T. Malasek, Chief Financial Officer & Secretary
  • Joseph Tauber, Chief Medical Officer
  • Jeffrey A. Busby, Senior Vice President-Business Development

What other stocks do shareholders of AXIM Biotechnologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AXIM Biotechnologies investors own include (CGC), Cronos Group (CRON), (APHA), Tilray (TLRY), KushCo (KSHB), Aurora Cannabis (ACB), Curaleaf (CURLF), Charlotte's Web (CWBHF), Fulcrum Therapeutics (FULC) and Alibaba Group (BABA).

What is AXIM Biotechnologies' stock symbol?

AXIM Biotechnologies trades on the OTCMKTS under the ticker symbol "AXIM."

How do I buy shares of AXIM Biotechnologies?

Shares of AXIM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AXIM Biotechnologies' stock price today?

One share of AXIM stock can currently be purchased for approximately $0.23.

How many employees does AXIM Biotechnologies have?

AXIM Biotechnologies employs 7 workers across the globe.

What is AXIM Biotechnologies' official website?

The official website for AXIM Biotechnologies is aximbiotech.com.

How can I contact AXIM Biotechnologies?

The company can be reached via phone at (858) 923-4422.

This page was last updated on 1/20/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.